( NASDAQ-NMS:ENDP, Toronto:ENDP )

News from Endo International plc A wide array of domestic and global news stories on topics including politics, business, technology, religion, sports, entertainment, science, health and lifestyle.

Latest News from Endo International plc

17 Apr, 2018, 21:48 BST Endo Receives Paragraph IV Notification on Vasostrict®

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Par Pharmaceutical, Inc. and Par Sterile Products, LLC, have received...


13 Apr, 2018, 12:30 BST Endo to Announce First-Quarter 2018 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its first-quarter 2018 financial results on May 8, 2018 and members of its senior management...


02 Apr, 2018, 12:30 BST Endo Agrees to Extend Temporary Stay of FDA Litigation

Endo International plc (NASDAQ: ENDP) today announced that it has agreed to extend a temporary stay of its litigation against the U.S. Food and...


01 Mar, 2018, 23:46 GMT Endo Obtains Preliminary Injunction Against QuVa Pharma, Inc. Preventing Marketing and Release of Vasopressin Product

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Par Pharmaceutical, Inc. and Par Sterile Products, LLC (Par),...


27 Feb, 2018, 11:00 GMT Endo Reports Fourth-Quarter And Full-Year 2017 Financial Results

- Fourth-quarter 2017 revenues of $769 million; Full-year 2017 revenues of $3,469 million - Fourth-quarter 2017 Sterile...


06 Feb, 2018, 12:30 GMT Endo Announces Initiation Of Two Pivotal Phase 3 Clinical Trials Of Collagenase Clostridium Histolyticum For The Treatment Of Cellulite

Endo International plc (NASDAQ: ENDP) today announced the initiation of two identical Phase 3 RELEASE* clinical trials of collagenase clostridium...


29 Jan, 2018, 12:30 GMT Endo to Announce Fourth-Quarter 2017 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter 2017 financial results on February 27, 2018 and members of its senior...


24 Jan, 2018, 22:14 GMT Endo Agrees to FDA's Request to Seek Temporary Litigation Stay

Endo International plc (NASDAQ: ENDP) today announced that it has agreed to a request by the U.S. Food and Drug Administration (FDA) to seek a...


11 Jan, 2018, 13:30 GMT Endo Comments on United States Attorney's Office Grand Jury Subpoena Relating to Products Containing Oxymorphone

Endo International plc (NASDAQ: ENDP) ("Endo") today announced that its subsidiary, Endo Pharmaceuticals Inc. ("EPI"), has received a grand jury...


28 Dec, 2017, 13:30 GMT Endo to Participate at the 36th Annual J.P. Morgan Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that Paul Campanelli, President and CEO, will participate in a fireside chat at the 36th...


17 Nov, 2017, 21:01 GMT Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference

Endo International plc (NASDAQ: ENDP) announced today that Blaise Coleman, Executive Vice President and Chief Financial Officer, will participate...


09 Nov, 2017, 21:01 GMT Endo Reports Third-Quarter 2017 Financial Results

- Third-quarter 2017 revenues of $787 million and reported $0.45 diluted (GAAP) loss per share from continuing operations -...


08 Nov, 2017, 21:47 GMT Endo Announces Appointment of Dr. Sharad S. Mansukani to Board of Directors and Resignation of Mr. Douglas S. Ingram

Endo International plc (NASDAQ: ENDP) today announced the appointment of Sharad S. Mansukani, M.D., CPE, CMCE to the Company's Board of Directors...


30 Oct, 2017, 12:30 GMT Endo Announces Certain Preliminary Financial Results for Third-Quarter 2017 and Affirms Selected 2017 Financial Guidance

Company Also Comments on Status of VASOSTRICT® (vasopressin injection, USP) Endo International plc (NASDAQ: ENDP) today announced certain...


26 Oct, 2017, 21:59 BST Endo Files Federal Lawsuit to Obtain FDA Compliance with Drug Quality and Security Act of 2013

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Par Sterile Products, LLC and Endo Par Innovation Company, LLC, filed...


25 Oct, 2017, 21:30 BST Endo Completes Divestiture of Grupo Farmacéutico SOMAR

Endo International plc (NASDAQ: ENDP) today announced the completion of the previously announced sale of Grupo Farmacéutico SOMAR to Advent...


09 Oct, 2017, 12:30 BST Endo to Announce Third-Quarter 2017 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its third-quarter 2017 financial results on November 9, 2017 and members of its senior...


26 Sep, 2017, 11:30 BST Four-Time PGA TOUR Winner Tim Herron Teams Up with Endo Pharmaceuticals to Encourage Adults to Get the Facts on Hand

- Educational campaign puts a spotlight on Dupuytren's Contracture, a medical condition that causes fingers to bend, making everyday tasks...


28 Aug, 2017, 12:30 BST Endo Begins Shipment of Generic Sabril® (vigabatrin) for Oral Solution

Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, has begun shipping vigabatrin for...


22 Aug, 2017, 12:30 BST Endo to Participate at Morgan Stanley Global Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that Paul Campanelli, President and CEO, will participate in a fireside chat at the Morgan...


08 Aug, 2017, 11:30 BST Endo Reports Second-Quarter 2017 Financial Results

- Second-quarter 2017 revenues of $876 million and reported $3.12 diluted (GAAP) loss per share from continuing operations -...


07 Aug, 2017, 21:30 BST Endo Announces Agreements to Resolve Virtually All Known U.S. Mesh Product Liability Claims

Endo International plc (NASDAQ: ENDP) today announced that it has reached agreements to resolve virtually all known U.S. mesh product liability...


21 Jul, 2017, 13:30 BST Endo to Restructure Manufacturing Network

Endo International plc (NASDAQ: ENDP) today announced that after completing a comprehensive review of its manufacturing network, the Company will...


14 Jul, 2017, 12:30 BST Endo to Announce Second-Quarter 2017 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its second-quarter 2017 financial results on Tuesday, August 8, 2017. Members of its senior...


06 Jul, 2017, 17:36 BST Endo Provides Update On OPANA® ER

Endo International plc (NASDAQ: ENDP) continues to believe in the safety, efficacy, and favorable benefit-risk profile of OPANA® ER (oxymorphone...